Desensitization
5
0
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
20.0%
1 terminated out of 5 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Impact of Dental Desensitization Facilitated by a Child Life Specialist Distress and Cooperation
Effectiveness of Resin-Based Desensitizer and Laser, Compared to Fluoride Varnish in Management of Dentine Hypersensitivity in Non-carious Cervical Lesions
Potassium Nitrate Gel and Diode Laser in the Treatment of Dentinal Hypersensitivity
Desensitization With Belimumab in Sensitized Patients Awaiting Kidney Transplant
Desensitization for Highly Sensitized Recipients of Pancreas Transplantation